Could a common supplement help tame type 2 diabetes?
NCT ID NCT04874012
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether taking taurine, a natural amino acid found in energy drinks and supplements, can improve blood sugar, cholesterol, and inflammation in people with type 2 diabetes. About 94 adults with diabetes will take either taurine powder or a placebo twice daily for 12 weeks. Researchers will measure changes in key health markers like HbA1c and cholesterol to see if taurine offers any benefit beyond standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
taurine
What this could lead to
If it works, this could point toward a simple, low-cost supplement to help manage blood sugar and cholesterol in type 2 diabetes.
What could go wrong
This is a small, early-phase trial with only 94 people. Taurine may not improve diabetes control significantly, and results may not apply to everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital de Clínicas
RECRUITINGPorto Alegre, Rio Grande do Sul, 90630090, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••